Ketorolac 0.4%
Sponsors
Alcon Research, Innovative Medical, Allergan
Conditions
InflammationMacula ThickeningPhotorefractive Keratectomy
Phase 4
A Comparison of Topical Nepafenac to Placebo in Corneal Epithelial Healing Times and Postoperative Pain Relief
CompletedNCT00330798
Start: 2006-02-28End: 2006-06-30Updated: 2016-11-18
Efficacy of Topical Ketorolac Versus Placebo for Improving Visual Outcomes Following Multifocal IOL Implantation
CompletedNCT00433225
Updated: 2007-09-10
Efficacy of Ketorolac 0.4% in Prostaglandin Suppression
CompletedNCT00791323
Start: 2008-11-30End: 2009-08-31Updated: 2011-09-23